Investment firm and company builder Accelerator Life Science Partners has launched Proniras Corporation, a US-based developer of seizure disorder treatments, with an undisclosed amount of funding from investors including Alexandria Venture Investments, Johnson & Johnson Innovation – JJDC and WuXi AppTec Corporate Ventures, respective subsidiaries of real estate investment trust Alexandria Real Estate Equities and pharmaceutical firms Johnson & Johnson and WuXi AppTec. The units were joined by pharmaceutical company Eli Lilly, Arch Venture Partners, Watson Fund and WRF Capital.
…
